scholarly journals RATIONAL PHARMACOTHERAPY BASED ON PHARMACOECONOMIC DATA AUDIT: PRINCIPLES AND APPLICATION IN BULGARIA

2014 ◽  
Vol 10 (4) ◽  
pp. 402-405
Author(s):  
T. Vekov
2015 ◽  
pp. 46-50
Author(s):  
G. Lezhenko ◽  
◽  
O. Pashkova ◽  
S. Sidorenko ◽  
◽  
...  

2019 ◽  
Vol 98 (3) ◽  
pp. 188-194
Author(s):  
A.P. Prodeus ◽  
◽  
M.V. Ustinova ◽  
A.U. Lekmanov ◽  
N.V. Kudryashov ◽  
...  

2008 ◽  
Vol 62 (3) ◽  
pp. 242-249 ◽  
Author(s):  
Lene Sorensen ◽  
Bent Nielsen ◽  
Kurt B Stage ◽  
Kim Brøsen Professor ◽  
Per Damkier

1998 ◽  
Vol 13 (1_suppl) ◽  
pp. S27-S29 ◽  
Author(s):  
Nina Graves

Two pharmacoeconomic studies on the treatment of acute seizures have been conducted. In 1991, Kriel and colleagues surveyed parents of children with a history of cluster seizures, prolonged seizures, or status epilepticus who had been instructed in the use of rectal diazepam. A comparison of data before instruction with data after instruction showed a reduced need for emergency department visits with rectal diazepam. Instruction thus provided a pharmacoeconomic benefit, despite the cost of the product. In 1996, Marchetti and coworkers found that intravenous fosphenytoin was associated with fewer adverse events than intravenous phenytoin. Fosphenytoin thus reduced the need for adverse event management and provided a substantial pharmacoeconomic benefit, despite its higher cost, compared with phenytoin. This study had a number of limitations, however, and hospital pharmacists remain resistant to the use of fosphenytoin. Additional studies may provide more pharmacoeconomic data to support the greater use of fosphenytoin in the treatment of acute pediatric seizures. (J Child Neurol 1998;13(Suppl 1):S27-S29).


2013 ◽  
Vol 9 (6) ◽  
pp. 701-707 ◽  
Author(s):  
A. V. Shulkin ◽  
E. N. Yakusheva ◽  
N. M. Popova

2008 ◽  
Vol 4 (2) ◽  
pp. 89-92
Author(s):  
M. P. Metrova ◽  
A. B. Salmina ◽  
A. I. Inzhutova ◽  
O. S. Bahmeteva

Sign in / Sign up

Export Citation Format

Share Document